- HIV infection has always been associated with reports of complex hormonal and metabolic abnormalities. Historically, the majority of such reports have been in ...
- Thanks to the widespread availability of potent combination anti-HIV therapy (ART) in Canada and other high-income countries, HIV-positive people are living ...
- Human papillomavirus (HPV) is a common sexually transmitted germ. Many different strains of HPV exist and can cause different complications such as ano-genital ...
- It is normal to have a variety of bacteria and a small amount of fungi in the vagina. However, some women can develop an imbalance in the bacteria in their ...
- As mentioned earlier in this issue of TreatmentUpdate, bacterial vaginosis (BV) is the result of an imbalance in the bacteria that live in the vagina. ...
- Research teams in the U.S. have been studying the health issues of women with or at high risk for HIV infection as part of a project called the Women’s ...
- An American randomized trial showed that short-term, intensive support for hospitalized HIV-positive people who use substances to navigate the health system does not have an impact on rates of viral…
- Prevention in FocusThis article explores why hepatitis C rates are higher among Canadian immigrants and newcomers, including common modes of transmission, and barriers related to testing, and provides recommendations…
- Prevention in FocusCATIE recently endorsed the Consensus Statement of the Prevention Access Campaign, celebrating the fact that “undetectable equals untransmittable.” This revolutionary statement, pushed forward by a…
- An American demonstration project has shown that young gay, bisexual and other men who have sex with men (MSM) who have sex that may expose them to HIV in an ongoing way find the care and support…
- A study has shown that 95% of participants in a rapid HIV treatment initiation program start antiretroviral treatment (ART) within 24 hours of being diagnosed with HIV.
- The fixed-dose combination of sofosbuvir + velpatasvir (sold as Epclusa) has activity against all major strains, or genotypes, of hepatitis C virus (HCV). The ...